Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (16)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Cotterill, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cotterill, S.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of Antimicrobial Chemotherapy (1995) 36, 773-780
© 1995 The British Society for Antimicrobial Chemotherapy

review-article

Antimicrobial prescribing in patients on baemofiltration

S. Cotterill

Microbiology Department, City Hospital NHS Trust Dudley Road, Birmingham B18 7QH, UK

Received 9 August 1994; returned 10 May 1995; accepted 22 June 1995

Continuous haemo(dia)filtration techniques as a means of extracorporeal renal replacement therapy are being used more and more, especially on intensive care units. The effect of intermittent haemodialysis on the pharmacokinetics of systemic antibiotics is well documented and advice is provided in the drug data sheets regarding dosage, timing and additional doses (post haemodialysis). Continuous haemofiltration significantly alters the handling of these same antibiotics compared with haemodialysis, such that if the advice given for ‘haemodialysis’ is used for patients on haemofiltration, under-dosing the patient may lead to sub-therapeutic antibiotic levels. The reasons for these differences are discussed and suggested dosage modifications are given for commonly used antimicrobials based on available published data.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J Antimicrob ChemotherHome page
V. Fuhrmann, P. Schenk, W. Jaeger, M. Miksits, N. Kneidinger, J. Warszawska, U. Holzinger, R. Kitzberger, and F. Thalhammer
Pharmacokinetics of voriconazole during continuous venovenous haemodiafiltration
J. Antimicrob. Chemother., November 1, 2007; 60(5): 1085 - 1090.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
R. Gattringer, B. Meyer, G. Heinz, C. Guttmann, M. Zeitlinger, C. Joukhadar, P. Dittrich, and F. Thalhammer
Single-dose pharmacokinetics of fosfomycin during continuous venovenous haemofiltration
J. Antimicrob. Chemother., August 1, 2006; 58(2): 367 - 371.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
V. Fuhrmann, P. Schenk, W. Jaeger, S. Ahmed, and F. Thalhammer
Pharmacokinetics of moxifloxacin in patients undergoing continuous venovenous haemodiafiltration
J. Antimicrob. Chemother., October 1, 2004; 54(4): 780 - 784.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
D. Breilh, B. Allaouchiche, H. Jaumain, P. Boulétreau, D. Chassard, I. Malbec, D. Ducint, and M.-C. Saux
Pharmacokinetics of Isepamicin during Continuous Venovenous Hemodiafiltration
Antimicrob. Agents Chemother., October 1, 1999; 43(10): 2409 - 2411.
[Abstract] [Full Text]

Home page
 Antimicrob. Agents Chemother.Home page
F. Thalhammer, P. Schenk, H. Burgmann, I. El Menyawi, U. M. Hollenstein, A. R. Rosenkranz, G. Sunder-Plassmann, S. Breyer, and K. Ratheiser
Single-Dose Pharmacokinetics of Meropenem during Continuous Venovenous Hemofiltration
Antimicrob. Agents Chemother., September 1, 1998; 42(9): 2417 - 2420.
[Abstract] [Full Text]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.